Speqta - New Versions and Data
2022-05-11 09:45:00
Redeye sees a stable Q1 report from Speqta, with the disclosed numbers regarding Bidbrain being the highlight. From now on, investors and we can track the development of Bidbrain, which will be Speta’s core asset following the dividend.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/